Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 2Phase 4 1Phase 2 1

Status

Completed 80Recruiting 58Unknown 20Not yet recruiting 14Terminated 13Withdrawn 12Active not recruiting 10Enrolling by invitation 3

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3

Conditions

Neoplasms 33Breast Neoplasms 26Colorectal Neoplasms 21Prostatic Neoplasms 18Uterine Cervical Neoplasms 13Anxiety Disorders 13Lung Neoplasms 7Urinary Bladder Neoplasms 6Lymphoma, Follicular 6Colonic Neoplasms 6Brain Neoplasms 6Pain 5Epilepsy 5Depression 5Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Dysplasia 4Ovarian Neoplasms 4Inflammation 4Head and Neck Neoplasms 4Dementia 4Carcinoma, Hepatocellular 4Stomach Neoplasms 3Smoking 3Sarcoma 3Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Neoplastic Syndromes, Hereditary 3Motor Activity 3Lymphedema 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Enrolling by invitation × Sarcoma × Clear all
NCT07528079 2026-04-16

Organoid-based Sensitivity-guided Chemotherapy for Advanced / Refractory Pediatric Tumors

Shanghai Jiao Tong University School of Medicine

Phase NA Enrolling by invitation
30 enrolled
Sarcoma

Sarcoma

NCT06743958 2025-05-28

Prehab4Kids

Technical University of Munich

Phase NA Enrolling by invitation
16 enrolled
Sarcoma

Bone Neoplasms, Neoplasms, Sarcoma

NCT06968884 2025-05-13

Application of a Comprehensive Protocol Aimed at Reducing the Risk of Complications After Surgery for Sarcoma. Interventions Before, During and After Surgery for Known and Presumed Risk Factors Compared to Standard of Care in a Total of 300 Patients.

Region Stockholm

Phase NA Enrolling by invitation
300 enrolled
Sarcoma

Sarcoma, Risk Reduction Behavior

Data powered by HemOnc (CC BY 4.0) Colophon âš¡